ESSENTIALIS INC has a total of 63 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are EGIS GYOGYSZERGYAR NYILVANOSAN MUKOEDO RESZVENYTARSASAG, SIDEM PHARMA and ALTAVANT SCIENCES GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Australia | 7 | |
#4 | China | 6 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | Canada | 4 | |
#7 | Hong Kong | 4 | |
#8 | Brazil | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | Hungary | 1 | |
#11 | Israel | 1 | |
#12 | Japan | 1 | |
#13 | Republic of Korea | 1 | |
#14 | Mexico | 1 | |
#15 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Cowen Neil M | 55 |
#2 | Kashkin Kenneth B | 20 |
#3 | Yamout Khaled A | 18 |
#4 | Dukes Lain | 4 |
#5 | Cowen Neil Madison | 3 |
#6 | Pasternark Richard C | 2 |
#7 | Neil M Cowen | 2 |
#8 | Pasternak Richard C | 1 |
#9 | Cowen Neil M Kashkin Kenneth B | 1 |
#10 | Kenneth B Kashkin B | 1 |
Publication | Filing date | Title |
---|---|---|
HUE050895T2 | Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome | |
US2016136178A1 | Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome | |
EP2819675A1 | Salts of potassium atp channel openers and uses thereof | |
AU2012203517A1 | Salts of potassium ATP channel openers and uses thereof | |
CN101795691A | Salts of potassium atp channel openers and uses thereof | |
EP3545958A1 | Salts of potassium atp channel openers and uses thereof | |
CN101043879A | Pharmaceutical formulations of potassium atp channel openers and uses thereof | |
AU2005280058A1 | Pharmaceutical formulations of potassium ATP channel openers and uses thereof |